You just read:

Regeneron and Sanofi Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA

News provided by

Regeneron Pharmaceuticals, Inc.

Apr 28, 2017, 01:00 ET